Economists Explain Policies Restricting Pharmacy Benefits Will Lead To Higher Costs, Less Competition, And Fewer Choices For Employers In case you missed it, Joe Grogan, visiting senior fellow at the USC Schaeffer Center and former White House domestic policy adviser,
Unlocking an Affordable Future Unlocking an Affordable Future NEWSROOM Alex Brill: Trends In The US Insulin Market: New Prices, New Players, New Dynamics NEWSROOM Alex Brill: Trends In The US Insulin Market: New Prices, New Players, New Dynamics Stop The
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement in response to a letter issued by the Centers for Medicare and Medicaid Services (CMS): “The Pharmaceutical Care Management Association, PCMA, representing America’s pharmacy benefit companies, believes it is
In case you missed it, Ike Brannon, health care economist and senior fellow at the Jack Kemp Foundation, published a new white paper, “Recently Proposed Federal and State Legislation To Constrain Pharmacy Benefit Managers Would Not Reduce Drug Costs,” in
Patient Care Pharmacy benefit companies work to lower prescription drug costs, improve patient access to prescription drugs, and offer benefits that protect a patient’s overall health. Health care plans hire pharmacy benefit companies, PBMs, to secure lower costs for prescription
(Washington, D.C.) — The number of independent pharmacies in the United States increased in 2020, according to a new analysis of pharmacy data. Pharmacy data from the National Council for Prescription Drug Programs, analyzed by the healthcare analytics firm Quest
By JC Scott, President and CEO, PCMA In the past few years, some have been pushing the narrative that pharmacy benefit companies are driving independent pharmacies out of business. Their argument seems compelling, but is it true? As we do
As Congress reviews legislation targeting Americans’ pharmacy benefits, Members of Congress are raising concerns about the unintended risks of significantly increasing drug costs. In case you missed it, Senator Rand Paul (R-KY) discusses recent legislation advanced by the Senate’s HELP
©2024 PCMA. All Rights Reserved.
